Johnson & Johnson Q3 FY26: where the revenue came from and where it went
The whole income statement of Johnson & Johnson for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jun 29 – Sep 27, 2026
Revenue$25.40B
+6% year over year
Gross profit$17.30B
68% margin
Operating profit$7.22B
28% margin
Net profit$0.21B
1% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 25.40 | 100% | +6% |
| Innovative medicine | 16.38 | 65% | +5% |
| MedTech | 8.93 | 35% | |
| Other revenue | 0.09 | 0% | |
| Cost of revenue | −8.10 | 32% | |
| Gross profit | 17.30 | 68% margin | −1pp |
| SG&A | −6.29 | 25% | +0pp |
| Other | −3.80 | 15% | +0pp |
| Operating profit | 7.22 | 28% margin | |
| Interest & other costs | −7.18 | ||
| Tax benefit | 0.18 | ||
| Net profit | 0.21 | 1% margin | −21pp |
28 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest